Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Total revenue from sales of goods and services
5Y CAGR
+157.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
113.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $172.35M | +627.8% |
| 2024 | $23.68M | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | -100.0% |
| 2021 | $139.71M | +9109.6% |
| 2020 | $1.52M | 0.0% |
| 2019 | $1.52M | 0.0% |
| 2018 | $1.52M | -28.0% |
| 2017 | $2.11M | +72.8% |
| 2016 | $1.22M | - |